Dianthus Therapeutics, Inc.

Director

• Define and execute the company-wide bioanalytical strategy, operating model, standards, and capability roadmap
• Lead bioanalytical support across research, translational, and clinical programs, including PK, pharmacodynamic, immunogenicity, neutralizing antibody, biomarker, and program-specific assays
• Provide scientific oversight for assay strategy, platform selection, critical reagents, method development, qualification and validation, technology transfer, sample analysis, data interpretation, and assay lifecycle management
• Ensure assays and data are fit for purpose, scientifically rigorous, compliant with regulatory expectations, and available for key program decisions and milestones
• Resolve complex assay, data, quality, and vendor issues with Quality, program teams, and external laboratories
• Own or oversee bioanalytical content for regulatory submissions, briefing packages, health authority interactions, responses, and development reports
• Represent Bioanalytical Sciences on program teams and governance forums, communicating scientific conclusions, risks, trade-offs, resource needs, and recommendations
• Build, lead, and develop the Bioanalytical Sciences function through organizational design, recruitment, coaching, performance management, succession planning, and capability development
• Develop and manage resourcing across employees, CROs, specialty laboratories, consultants, and technology partners
• Lead external laboratory evaluation, selection, contracting input, onboarding, governance, performance management, issue escalation, and relationship management
• Own functional budgets, headcount plans, consultant needs, capacity forecasts, and resource allocation
• Establish processes, metrics, systems, and vendor oversight practices supporting quality, speed, accountability, and inspection readiness; evaluate technologies improving scientific and operational performance

Executive Director – Bioanalytical Sciences